Terms: = Liver cancer AND ER, estrogen receptor AND Treatment
778 results:
1. Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
Tian Y; Wang Y; Wen N; Wang S; Li B; Liu G
BMC Cancer; 2024 Apr; 24(1):426. PubMed ID: 38584263
[TBL] [Abstract] [Full Text] [Related]
2. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
[TBL] [Abstract] [Full Text] [Related]
3. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
[TBL] [Abstract] [Full Text] [Related]
4. treatment patterns and clinical outcomes of chidamide combined with endocrine therapy in hormone receptor-positive, HER2-negative metastatic breast cancer: A real-world multicenter study.
Li D; Jin Y; Lin M; Zeng C; Guo Q; Liu Y; Zhang J
Cancer Med; 2024 Feb; 13(4):e6762. PubMed ID: 38457252
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of HER2-Positive Advanced Breast cancer Who Was Able to Start and Continue Chemotherapy Despite liver Damage Due to Diffuse liver Metastasis].
Fujimoto T; Maeda N; Ioka T; Nagano H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1739-1741. PubMed ID: 38303191
[TBL] [Abstract] [Full Text] [Related]
7. An ER-targeted, Viscosity-sensitive Hemicyanine Dye for the Diagnosis of Nonalcoholic Fatty liver and Photodynamic cancer Therapy by Activating Pyroptosis Pathway.
Zeng S; Wang Y; Chen C; Kim H; Liu X; Jiang M; Yu Y; Kafuti YS; Chen Q; Wang J; Peng X; Li H; Yoon J
Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202316487. PubMed ID: 38197735
[TBL] [Abstract] [Full Text] [Related]
8. Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway.
Wu M; Wang J; Zhou W; Wang M; Hu C; Zhou M; Jiao K; Li Z
Chem Biol Interact; 2024 Feb; 389():110865. PubMed ID: 38191086
[TBL] [Abstract] [Full Text] [Related]
9. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract] [Full Text] [Related]
10. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
[TBL] [Abstract] [Full Text] [Related]
11. Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122.
Liang YJ; Chiou YW; Chiu AP; Shiao MS; Teng W; Lin CW; Cheng ML; Huang YH; Liang KH; Su CW; Lai CY; Chen CL; Wu JC
J Med Virol; 2023 Dec; 95(12):e29325. PubMed ID: 38108211
[TBL] [Abstract] [Full Text] [Related]
12. The role of sex hormones and receptors in HBV infection and development of HBV-related HCC.
Nuermaimaiti A; Chang L; Yan Y; Sun H; Xiao Y; Song S; Feng K; Lu Z; Ji H; Wang L
J Med Virol; 2023 Dec; 95(12):e29298. PubMed ID: 38087447
[TBL] [Abstract] [Full Text] [Related]
13. SPRTN is involved in hepatocellular carcinoma development through the ER stress response.
Batel A; Polović M; Glumac M; Šuman O; Jadrijević S; Lozić B; Petrović M; Samardžija B; Bradshaw NJ; Skube K; Palada V; Acman M; Marinović Terzić I
Cancer Gene Ther; 2024 Mar; 31(3):376-386. PubMed ID: 38086993
[TBL] [Abstract] [Full Text] [Related]
14. Contrastive Learning for Preoperative Early Recurrence Prediction of Hepatocellular Carcinoma with liver CT Image and Tumor Mask.
Xu Y; Zhao J; Chen Q; Wang F; Lin L; Hu H; Tong R; Li J; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083328
[TBL] [Abstract] [Full Text] [Related]
15. XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma.
Hendi Z; Asadi Sarabi P; Hay D; Vosough M
Expert Opin Ther Targets; 2023; 27(12):1207-1215. PubMed ID: 38078890
[TBL] [Abstract] [Full Text] [Related]
16. A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Watanabe S; Furuya N; Nakamura A; Shiihara J; Nakachi I; Tanaka H; Nakao M; Minato K; Seike M; Sasaki S; Kisohara A; Takeuchi S; Honda R; Takamura K; Kagamu H; Yoshimura K; Kobayashi K; Kikuchi T
Eur J Cancer; 2024 Jan; 197():113469. PubMed ID: 38061214
[TBL] [Abstract] [Full Text] [Related]
17. A Case Report of a Rare ER+, PR- Pure Metaplastic Breast Squamous Cell Carcinoma with HER2 Overexpression.
Adam SA; Kamaruddin KN; Abd Shukor N; Abdullah Suhaimi SN; Ismail F; Md Yasin M
Am J Case Rep; 2023 Dec; 24():e941448. PubMed ID: 38048289
[TBL] [Abstract] [Full Text] [Related]
18. estrogen receptor-mediated health benefits of phytochemicals: a review.
Li J; Yu J; Zou H; Zhang J; Ren L
Food Funct; 2023 Dec; 14(24):10681-10699. PubMed ID: 38047630
[TBL] [Abstract] [Full Text] [Related]
19. Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody.
Liu B; Xie N; Tian C; Feng R; Hu ZY; Li J; Liu L; Xiao H; Yang X; Zeng M; Wu H; Lu J; Gao J; Hu X; Cao M; Shui Z; Tang Y; Wu T; Ouyang Q
Breast; 2023 Dec; 72():103597. PubMed ID: 37944341
[TBL] [Abstract] [Full Text] [Related]
20.
Wang D; Zhang R; Qin X; Wang J; Hu Y; Lu S; Kan J; Ge Y; Jin K; Zhang WS; Liu Y
Int J Biol Sci; 2023; 19(16):5074-5088. PubMed ID: 37928262
[TBL] [Abstract] [Full Text] [Related]
[Next]
